FRI0731 Assessing the risk of rapid radiologic progression in hungarian rheumatoid arthritis patients

Background Prognosis of rheumatoid arthritis (RA) should be assessed early during the disease course. Rapid radiological progression (RRP) has been defined as a ≥% unit increase in van der Heijde-Sharp score within a year. The matrix risk model has been developed by Vastesaeger et al in 2009. This tool calculates RRP based on non-radiographic indicators such as baseline CRP, RF and swollen joint count. Objectives We wished to test the matrix prediction model int he very first Hungarian cohort study. Methods In this non-interventional, cross-sectional retrospective study carried out in 11 Hungarian arthritis centres, we assessed high risk (≥40%) of RRP in biologic-naive RA patients with active disease. In order to obtain a representative sample, patients were selected from each centre by a random technique. RRP was calculated according to the matrix model described by Vastesaeger et al. As a secondary endpoint, we compared methotrexate (MTX) responders vs non-responders with respect to RRP. Results We screened data of 1843 RA patients. Finally, data obtained from 1356 patients could be used for RRP prediction and MTX responsiveness. The mean age of patients was 55.5 years, 84.7% were women. The mean disease duration was 8.4 years. At the time of the assessment, mean CRP was 17.7 mg/l, RF was 139,3 IU/ml, mean DAS28 was 5.00 and mean swollen joint count was 6.56. High risk ((≥40%) of RRP could be determined in 18.2% of patients. Among continuous variables other than those used for calculation of RRP risk, RA patients with the risk of RRP≥40% (n=247) had significantly lower age than those with RRP Conclusions In the first bioloigc-naive Hungarian RA cohort assessed for RRP, RRP occurs in almost one-fifth of the patients. These patients differ from others in various clinical and serological parameters. RRP has also been associated with non-response to MTX. References Vastesaeger N, Xu S, Aletaha D, St Clair EW, Smolen JS. A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritis. Rheumatology (Oxford). 2009 Sep;48(9):1114–21. Disclosure of Interest None declared